Mebendazole Sameko

Mebendazole, the active ingredient in Mebendazole Sameko, is an anthelmintic presented as an oral dosage form for oral use. It is used to treat intestinal worm infections caused by common helminths in children and adults. GNH USA supplies Mebendazole Sameko as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mebendazole is an anthelmintic that targets intestinal nematode infections. - Ascariasis: eliminates Ascaris lumbricoides worms, relieving gastrointestinal symptoms. - Trichuriasis: eradicates Trichuris trichiura, reducing abdominal discomfort and dysentery. - Hookworm infection: removes Ancylostoma duodenale and Necator americanus, improving anemia and nutrient absorption. - Pinworm infection: clears Enterobius vermicularis, stopping perianal itching and reinfection.

Mebendazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Abdominal pain: mild to moderate discomfort in the stomach area. - Nausea: feeling of queasiness that may precede vomiting. - Vomiting: expulsion of stomach contents. - Diarrhoea: loose or watery stools. - Headache: mild to moderate head pain. - Dizziness: sensation of light‑headedness or unsteadiness.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Liver enzyme elevation: signs of hepatic stress detectable in blood tests. - Neutropenia: reduced white blood cell count increasing infection risk. - Stevens‑Johnson syndrome: rare severe skin reaction requiring immediate medical attention.

Before using Mebendazole Sameko, consider the following precautions. - Pregnancy: consult a healthcare professional; safety data are limited. - Breastfeeding: avoid unless benefits outweigh potential risks to the infant. - Liver disease: use with caution; monitor hepatic function if indicated. - Drug interactions: review all concomitant medications with a pharmacist or physician. - Storage: Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Mebendazole may interact with other medicines; awareness of interaction severity helps manage risk.

Major Interactions (Avoid): - Cimetidine: may increase mebendazole plasma concentrations. - Griseofulvin: may reduce the antiparasitic efficacy of mebendazole. - Carbamazepine: may lower mebendazole levels, reducing therapeutic effect.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., ketoconazole): may affect metabolic clearance. - Warfarin: may enhance anticoagulant activity, requiring INR monitoring.